Obesidad mórbida y dislipemia: impacto de la cirugía bariátrica

Ravussin, 1992, Pathophysiology of obesity, Lancet., 340, 404, 10.1016/0140-6736(92)91480-V Basterra-Gortari, 2011, Increasing trend in the prevalence of morbid obesity in Spain: From 1.8 to 6.1 per thousand in 14years, Rev Esp Cardiol., 64, 424, 10.1016/j.recesp.2010.06.010 Gutiérrez-Fisac, 2012, Prevalence of general and abdominal obesity in the adult population of Spain, 2008-2010: The ENRICA study, Obes Rev., 13, 388, 10.1111/j.1467-789X.2011.00964.x Aranceta-Bartrina, 2016, Prevalence of general obesity and abdominal obesity in the Spanish adult population (aged 25-64years) 2014-2015: The ENPE study, Rev Esp Cardiol., 69, 579, 10.1016/j.recesp.2016.02.010 Grundy, 2004, Obesity, metabolic syndrome, and cardiovascular disease, J Clin Endocrinol Metab., 89, 2595, 10.1210/jc.2004-0372 Goday, 2015, Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology, Clin Transl Oncol., 17, 763, 10.1007/s12094-015-1306-y Franssen, 2011, Obesity and dyslipidemia, Med Clin North Am., 95, 893, 10.1016/j.mcna.2011.06.003 Arner, 2005, Human fat cell lipolysis: Biochemistry, regulation and clinical role, Best Pract Res Clin Endocrinol Metab., 19, 471, 10.1016/j.beem.2005.07.004 Ginsberg, 2006, Metabolic syndrome: Focus on dyslipidemia, Obesity., 14, 41S, 10.1038/oby.2006.281 Grundy, 1997, Small LDL, atherogenic dyslipidemia, and the metabolic syndrome, Circulation., 95, 1, 10.1161/01.CIR.95.1.1 Piepoli, 2016, 2016 European guidelines on cardiovascular disease prevention in clinical practice, Eur Heart J., 37, 2315, 10.1093/eurheartj/ehw106 Stone, 2014, 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults, J Am Coll Cardiol., 63, 2889, 10.1016/j.jacc.2013.11.002 Fruchart, 2008, The residual risk reduction initiative: A call to action to reduce residual vascular risk in dyslipidaemic patients, Diabetes Vasc Dis Res., 5, 319, 10.3132/dvdr.2008.046 Sobenin, 1996, Atherogenic modified LDL in diabetes, Diabetes., 45, S35, 10.2337/diab.45.3.S35 Pedro-Botet, 2014, Dislipemia aterogénica: prevalencia y control en las unidades de lípidos, Rev Clin Esp., 214, 491, 10.1016/j.rce.2014.06.001 Sjöström, 2004, Lifestyle, diabetes, and cardiovascular risk factors 10years after bariatric surgery, N Engl J Med., 351, 2683, 10.1056/NEJMoa035622 2014, Eight-year weight losses with an intensive lifestyle intervention: The look AHEAD study, Obesity., 22, 5, 10.1002/oby.20662 Buchwald, 2004, Bariatric surgery: A systematic review and meta-analysis, JAMA., 292, 1724, 10.1001/jama.292.14.1724 Vidal, 2013, Laparoscopic gastric bypass versus laparoscopic sleeve gastrectomy as a definitive surgical procedure for morbid obesity. Mid-term results, Obes Surg., 23, 292, 10.1007/s11695-012-0828-4 Abdeen, 2016, Mechanism underlying the weight loss and complications of Roux-en-Y gastric bypass. Review, Obes Surg., 26, 410, 10.1007/s11695-015-1945-7 Dar, 2012, GLP-1 response to a mixed meal: What happens 10years after Roux-en-Y gastric bypass (RYGB)?, Obes Surg., 22, 1077, 10.1007/s11695-012-0624-1 Pournaras, 2012, The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control, Endocrinology., 153, 3613, 10.1210/en.2011-2145 Furet, 2010, Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: Links with metabolic and low-grade inflammation markers, Diabetes., 59, 3049, 10.2337/db10-0253 Marceau, 1998, Biliopancreatic diversion with duodenal switch, World J Surg., 22, 947, 10.1007/s002689900498 Regan, 2003, Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient, Obes Surg., 13, 861, 10.1381/096089203322618669 Felberbauer, 2008, Laparoscopic sleeve gastrectomy as an isolated bariatric procedure: Intermediate-term results from a large series in three Austrian centers, Obes Surg., 18, 814, 10.1007/s11695-008-9483-1 Schauer, 2014, Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes, N Engl J Med., 370, 2002, 10.1056/NEJMoa1401329 Peterli, 2012, Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: A randomized, prospective trial, Obes Surg., 22, 740, 10.1007/s11695-012-0622-3 Angrisani, 2017, Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014, Obes Surg., 27, 2279, 10.1007/s11695-017-2666-x Lecube, 2016, Trends in bariatric surgery in Spain in the twenty-first century: Baseline results and 1-month follow up of the RICIBA, a national registry, Obes Surg., 26, 1836, 10.1007/s11695-015-2001-3 Vidal, 2008, Type2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects, Obes Surg., 18, 1077, 10.1007/s11695-008-9547-2 Carswell, 2016, A systematic review and meta-analysis of the effect of gastric bypass surgery on plasma lipid levels, Obes Surg., 26, 843, 10.1007/s11695-015-1829-x Millán Núñez-Cortés, 2014, Dislipidemia aterogénica y riesgo residual. Estado de la cuestión en 2014, Clin Invest Arterioscler., 26, 287 Asztalos, 2010, Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women, J Lipid Res., 51, 2405, 10.1194/jlr.P900015-JLR200 Habib, 2009, Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis, Am J Cardiol., 104, 1251, 10.1016/j.amjcard.2009.06.042 Climent, 2016, Atherogenic dyslipidemia remission 1year after bariatric surgery, Obes Surg., 27, 1548, 10.1007/s11695-016-2504-6 Osland, 2017, Weight loss outcomes in laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: A meta-analysis and systematic review of randomized controlled trials, Surg Laparosc Endosc Percutan Tech., 27, 8, 10.1097/SLE.0000000000000374 Cho, 2015, Effect of sleeve gastrectomy on type 2 diabetes as an alternative treatment modality to Roux-en-Y gastric bypass: Systemic review and meta-analysis, Surg Obes Relat Dis., 11, 1273, 10.1016/j.soard.2015.03.001 Zhang, 2015, Laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass for morbid obesity and related comorbidities: A meta-analysis of 21 studies, Obes Surg., 25, 19, 10.1007/s11695-014-1385-9 Shoar, 2017, Long-term and midterm outcomes of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass: A systematic review and meta-analysis of comparative studies, Surg Obes Relat Dis., 13, 170, 10.1016/j.soard.2016.08.011 Nguyen, 2006, Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass, J Am Coll Surg., 203, 24, 10.1016/j.jamcollsurg.2006.03.019 Benetti, 2013, Cholesterol metabolism after bariatric surgery in grade3 obesity: Differences between malabsorptive and restrictive procedures, Diabetes Care., 36, 1443, 10.2337/dc12-1737 Boza, 2012, Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy: A case-control study and 3years of follow-up, Surg Obes Relat Dis., 8, 243, 10.1016/j.soard.2011.08.023 Serrano, 2016, Excess weight loss and cardiometabolic parameter reduction diminished among Hispanics undergoing bariatric surgery: Outcomes in more than 2,000 consecutive Hispanic patients at a single institution, J Am Coll Surg., 222, 166, 10.1016/j.jamcollsurg.2015.10.009 Benaiges, 2012, Impact of restrictive (sleeve gastrectomy) vs hybrid bariatric surgery (Roux-en-Y gastric bypass) on lipid profile, Obes Surg., 22, 1268, 10.1007/s11695-012-0662-8 Vix, 2013, Evolution of glycolipid profile after sleeve gastrectomy vs Roux-en-Y gastric bypass: Results of a prospective randomized clinical trial, Obes Surg., 23, 613, 10.1007/s11695-012-0827-5 Climent, 2018, Laparoscopic Roux-en-Y gastric bypass vs. laparoscopic sleeve gastrectomy for morbid obesity: A systematic review and meta-analysis of lipid effects at one year post-surgery, Minerva Endocrinol., 43, 87, 10.23736/S0391-1977.17.02627-X Lee, 2015, Medium-term results of laparoscopic sleeve gastrectomy: A matched comparison with gastric bypass, Obes Surg., 25, 1431, 10.1007/s11695-015-1582-1 Schauer, 2017, Bariatric surgery versus intensive medical therapy for diabetes-5-year outcomes, N Engl J Med., 376, 641, 10.1056/NEJMoa1600869 Zhang, 2014, A randomized clinical trial of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy for the treatment of morbid obesity in China: A 5-year outcome, Obes Surg., 24, 1617, 10.1007/s11695-014-1258-2 Salminen, 2018, Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5years among patients with morbid obesity: The SLEEVEPASS randomized clinical trial, JAMA., 319, 241, 10.1001/jama.2017.20313 Peterli, 2018, Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: The SM-BOSS randomized clinical trial, JAMA., 319, 255, 10.1001/jama.2017.20897 Climent, 2018, Changes in the lipid profile 5years after bariatric surgery: Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy, Surg Obes Relat Dis., 14, 1099, 10.1016/j.soard.2018.05.006